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Results and Discussion

Abstract
Theranostic agents, a class of molecules that simultaneously serve both
a diagnostic and therapeutic function, enable in vivo imaging for early
diagnosis and targeted drug delivery within a single entity. Due to recent
advances in the synthesis and photophysical properties of the rhodamine
scaffold, rhodamine dyes present a promising new direction for
theranostic research. Toward the goal of exploring rhodamine dyes as
self-immolative prodrugs for theranostic applications, we have
synthesized a rhodamine precursor via a telescoped radical
bromination/hydrolysis. Upon completion of the full rhodamine synthesis,
we will explore and optimize the kinetics of its “turn-on” fluorescence and
drug release in vitro.

Future Work

Failed NBS Radical Bromination

Completion of the Rhodamine Synthesis
Scheme 7. Proposed mechanism of rhodamine formation

Scheme 4: Failed radical bromination due to hydrolysis

Theranostic Agents
• Many cancers go undetected until late-stage, when prognosis is
poor1; thus early detection is vital to improving patient outcomes2
• Theranostic enables simultaneous in vivo
imaging for early diagnosis and
targeted drug delivery within a
single entity3
• Single-molecular theranostic
agents (SMTA) offer the
benefit of synthetic modularity,
higher membrane permeability,
Figure 1. Cancer theranostic enables
easier renal clearance,
both diagnostic imaging and drug
4
and a cheaper cost of production
delivery7

Self Immolative Molecules
• They consist of three parts: self-immolative spacers, trigger moieties,
and a substrate such as drug5
• Upon stimulus, cleavage of the trigger moiety occurs along with a
cascade of disassembly reactions which result in the release of the
substrate6

Derivatization of Commercially Available Rhodamines
Scheme 8. Functionalization of Rhodamine 6G
Figure 3. 1H NMR spectrum from attempted radical
bromination, showing disappearance of TBS protecting group,
suggesting hydrolysis
• Originally, we attempted to obtain phenol 4 via a radical bromination to yield bromide 7. This
would be followed by hydrolysis with dioxane/water.
• TLC and 1H NMR from the attempted NBS bromination suggested the product quickly
underwent hydrolysis to form a mixture of products, including the originally desired alcohol 4
as the major product (figure 3)
• This inspired us to experiment with a telescoped bromination and hydrolysis (scheme 5)
Scheme 5. Telescoped radical bromination and hydrolysis
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+
Hydrolysis

Rhodamine 6G

Testing Kinetics of Self-Immolative Process

Telescoped NBS Bromination and Hydrolysis
• Telescoping is a technique in organic synthesis in which a reactant is
subjected to successive chemical reactions in one flask.
• By telescoping the NBS bromination and hydrolysis, an intermediate workup
and purification step is avoided (scheme 5)
• The product of the telescoped reaction was confirmed via 1H NMR (figure 4)
and mass spectrometry (figure 5)
Scheme 6. Synthesis of para-functionalized Rhodamine

Figure 2. Overview of a self-immolative prodrug process
Scheme 1. Mechanism of self-immolative prodrug

• Test the kinetics of the self-immolative drug release mechanism by
attaching a fluorinated reporter to the labile thiocarbonate and a
disulfide-based trigger to the aniline.
• Monitor the progress of the self-immolation reaction via the release of
the fluorinated motif using 19F-NMR
• Based on the data collected from these tests, the optimal isomer will
be further modified to improve the time it takes for the drug to be
released

Conclusions
• We have synthesized a para-rhodamine precursor in 2 steps and
22.5% overall yield
• Developed a telescoped radical bromination and hydrolysis that
creates a more efficient synthesis of the rhodamine scaffold that
eliminates an extra workup and purification step

Rhodamine
• The goal of this research is to explore rhodamine dyes as selfimmolative prodrugs for theranostic applications
• We aim to develop an efficient synthesis of polysubstituted
rhodamines and optimize the kinetics of “turn-on” fluorescence and
drug release in vitro
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